Epoch Investment Partners Inc. Sells 59,842 Shares of HCA Healthcare, Inc. $HCA

Epoch Investment Partners Inc. cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 12.7% in the first quarter, Holdings Channel reports. The institutional investor owned 412,897 shares of the company’s stock after selling 59,842 shares during the period. HCA Healthcare makes up about 1.2% of Epoch Investment Partners Inc.’s investment portfolio, making the stock its 11th biggest holding. Epoch Investment Partners Inc.’s holdings in HCA Healthcare were worth $195,399,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of HCA. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth approximately $26,000. Ares Financial Consulting LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $31,000. Cedar Mountain Advisors LLC purchased a new position in HCA Healthcare in the 1st quarter worth about $33,000. MCF Advisors LLC grew its stake in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after acquiring an additional 49 shares in the last quarter. Finally, Basepoint Wealth LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $35,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Up 1.5%

Shares of HCA Healthcare stock opened at $382.28 on Friday. The firm’s 50 day moving average price is $386.95 and its 200-day moving average price is $453.73. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company has a market cap of $84.80 billion, a P/E ratio of 13.15, a PEG ratio of 1.27 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. During the same quarter in the prior year, the business posted $6.84 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 29.19 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research reports. Argus reduced their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft dropped their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Truist Financial set a $413.00 price objective on shares of HCA Healthcare in a research note on Thursday, June 4th. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Finally, Wells Fargo & Company set a $369.00 target price on HCA Healthcare in a report on Monday. Fourteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $483.45.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.